Vetoquinol - Universal Registration Document - 2021

6 VETOQUINOL SA FINANCIAL STATEMENTS 6.1 CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME 130 6.2 CONSOLIDATED STATEMENT OF FINANCIAL POSITION 131 6.3 CONSOLIDATED STATEMENT OF CASH FLOWS 132 6.4 STATEMENT OF CHANGES IN CONSOLIDATED EQUITY 133 6.5 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 134 6.5.1 Overview 134 6.5.2 Key events 134 6.5.3 Accounting principles 134 6.5.4 Financial risk management 137 6.5.5 Capital management 140 6.5.6 Information on judgments and estimates 140 6.5.7 Business combinations 141 6.5.8 Operating segments – IFRS 8 142 6.5.9 R&D costs 145 6.5.10 Other purchases and external expenses 146 6.5.11 Staff costs 146 6.5.12 Share-based payments – bonus shares 147 6.5.13 Other operating income and expenses 147 6.5.14 Non-recurring operating income and expenses 147 6.5.15 Leases - IFRS 16 148 6.5.16 EBITDA 149 6.5.17 Net financial income 150 6.5.18 Income tax 150 6.5.19 Earnings per share 152 6.5.20 Goodwill 153 6.5.21 Intangible assets 156 6.5.22 Property, plant and equipment 157 6.5.23 IFRS 5 159 6.5.24 Other financial assets 159 6.5.25 Derivatives 159 6.5.26 Reconciliation of the change in working capital in the cash flow statement 160 6.5.27 Inventories 160 6.5.28 Trade and other receivables 161 6.5.29 Cash and cash equivalents 162 6.5.30 Capital stock and additional paid-in capital 162 6.5.31 Financial liabilities 163 6.5.32 Provisions for employee benefits 165 6.5.33 Other provisions 168 6.5.34 Trade and other payables 169 6.5.35 Assets and liabilities by accounting category 170 6.5.36 Dividends per share 171 6.5.37 Headcount 171 6.5.38 Off-balance sheet commitments 171 6.5.39 Contingent assets and liabilities 172 6.5.40 Related party disclosures 172 6.5.41 Post-balance sheet events 172 6.5.42 Litigation and arbitration 173 6.5.43 Financial/commercial position 173 6.5.44 Fees 173 6.5.45 Group companies 174 6.6 STATUTORY AUDITOR’S REPORT ON THE CONSOLIDATED FINANCIAL STATEMENTS 176 6.6.1 Opinion 176 6.6.2 Basis of opinion 176 6.6.3 Justification of assessments - Key audit matters 177 6.6.4 Specific testing 178 6.6.5 Other specific testing as required by the laws and regulations in force 178 6.6.6 Responsibilities of management and persons charged with governance of the Company in relation to the consolidated financial statements 179 6.6.7 Responsibilities of the statutory auditors in the audit of the consolidated financial statements 179 Vetoquinol Universal Registration Document 2020 Financial report 63